ALFA Filings
Every announcement, straight from the exchange
Every Zydus Lifesciences product launch announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Zydus Lifesciences, in partnership with MSN Laboratories, launched the first generic version of Riociguat Tablets (Adempas®) in the U.S. market.
Zydus Lifesciences launched REVAHALE, India's first once-daily nebulised LAMA for COPD treatment. This therapy offers 24-hour bronchodilation for patients unable to use standard handheld inhalers.
Zydus Lifesciences announced an MoU with Apollo Hospitals to bring the Shield™ Multi‑Cancer Detection test to India. The partnership aims to expand cancer screening across the country.